Adelaide start-up OmnigenIQ has developed a groundbreaking bioreactor technology for use in space, allowing for the production of essential biological supplements vital for human health during long-term space missions. This system synthesizes proteins crucial for maintaining muscle mass, bone density, and overall cellular function, reducing the need for costly resupplies from Earth. Co-founder Tiffanwy Klippel-Cooper highlights the dual-purpose applications of the technology, from supporting astronaut health on space missions to creating therapeutic proteins and surgical consumables on Earth.
The company is part of Australia’s first space accelerator program, Venture Catalyst Space, which aims to support the growth of innovative space start-ups. The program has so far supported 40 start-ups, attracting over AUD43 million in investment and grants and creating 240 jobs. South Australia Space Industry Centre Director Dr. Catherine Grace emphasizes the importance of such programs in building critical space capabilities and driving economic growth in the state.
UniSA Deputy Director Craig Jones emphasizes the role of diversification in the expanding space industry, with a focus on dual-use technologies that have applications in both space and terrestrial markets. The Venture Catalyst Space program, supported by the South Australian Government and UniSA, aims to empower early-stage space entrepreneurs to create globally scalable enterprises.
Overall, the development of new and affordable space technologies through programs like Venture Catalyst Space is crucial for enabling smaller enterprises to enter the sector and driving innovation in both space and Earth-based industries.
Source
Photo credit spaceanddefense.io
